Search results for "From ACP Diabetes Monthly"
Metformin use associated with improved outcomes in patients with historical contraindications
Studies were included in the review if they were published in English and included adults with type 2 diabetes and CKD, CHF, or chronic liver disease with hepatic impairment; compared regimens ... All articles from the January 27, 2017, ACP
January 2017
From ACP Diabetes Monthly
To evaluate the association of diabetes and recent weight change with pancreatic cancer, researchers used data from female participants in the Nurses' Health Study and male participants in the Health Professionals ... All articles from the September 25,
September 2020
From ACP Diabetes Monthly
Results from this small study suggest that reducing adipose tissue volume, by whatever means, will improve blood glucose control in patients with type 2 diabetes, an accompanying editorial noted. ... All articles from the September 25, 2020, ACP
September 2020
From ACP Diabetes Monthly
Researchers used data from the National Patient-Centered Clinical Research Network to compare diabetes-related outcomes in adults with type 2 diabetes who had either RYGB or sleeve gastrectomy between Jan. ... All articles from the March 27, 2020, ACP
March 2020
Incretin-based drugs not associated with any increase in risk for pancreatic diseases
population to study people with type 2 diabetes diagnosed after 2004 who received metformin plus a dipeptidyl peptidase-4 inhibitor (DPP-4) (n=50,095), glucagon-like peptide-1 (GLP-1) ... All articles from the November 27, 2018, ACP Gastroenterology
November 2018